Delivery Order SPE2DB22D3501-SPE2DB25FVG88
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.89 firm fixed-price delivery order is for the supply of 4,568,249,081 units of the prescription medication Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.80 firm fixed-price delivery order covers the procurement of 4,567,343,614 units of Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,439.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,092,208 capsules of the prescription medication Mesalamine DR 400 mg, with a performance period extending through May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,718.71 firm fixed price delivery order is for the supply of 180 capsules of the prescription drug Mesalamine DR 400 mg. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 with a performance...
This federal contract award, valued at $12,703.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of 4,565,805,308 units of Mesalamine 800 mg delayed-release tablets in 180-count bottles. This is a delivery order contract with a firm-fixed price, and the ultimate completion date is September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,561.93, is for the supply of 180 capsules of the medication Mesalamine DR 400 mg. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,320.11 firm fixed-price delivery order is for the supply of 4,564,158,406 capsules of Mesalamine DR 400 mg, a pharmaceutical product used for medical treatment. The contract has an ultimate completion date of April 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,585.73, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 180 capsules of the medication Mesalamine DR 400 mg. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical division, valued up to $999,999,999.00 through December 2025. This single-award IDC serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 400 mg capsules (180s). The contract has a ceiling value of $2,632.04 and a completion date of June 13, 2025. The award is not set aside and was made on June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mesalamine DR 400 mg Capsule (180s). The contract has a ceiling value of $2,666.26 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...